Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis

P Nallasamy, RK Nimmakayala, S Parte, AC Are… - Molecular cancer, 2022 - Springer
Cancer divergence has many facets other than being considered a genetic term. It is a
tremendous challenge to understand the metastasis and therapy response in cancer …

Crosstalk of inflammatory cytokines within the breast tumor microenvironment

O Habanjar, R Bingula, C Decombat… - International journal of …, 2023 - mdpi.com
Several immune and immunocompetent cells, including dendritic cells, macrophages,
adipocytes, natural killer cells, T cells, and B cells, are significantly correlated with the …

The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches

D Cruceriu, O Baldasici, O Balacescu… - Cellular Oncology, 2020 - Springer
Background Breast cancer is the most prevalent cancer among women worldwide and the
fifth cause of death among all cancer patients. Breast cancer development is driven by …

Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1α and beyond

SY Tam, VWC Wu, HKW Law - Frontiers in oncology, 2020 - frontiersin.org
Metastasis is the main cause of cancer-related mortality. Although the actual process of
metastasis remains largely elusive, epithelial-mesenchymal transition (EMT) has been …

Partial EMT in head and neck cancer biology: a spectrum instead of a switch

A Pal, TF Barrett, R Paolini, A Parikh, SV Puram - Oncogene, 2021 - nature.com
Our understanding of epithelial-to-mesenchymal transition (EMT) has slowly evolved from a
simple two state, binary model to a multi-step, dynamic continuum of epithelial-to …

NF-kappaB is involved in the regulation of EMT genes in breast cancer cells

BRB Pires, AL Mencalha, GM Ferreira, WF De Souza… - PloS one, 2017 - journals.plos.org
The metastatic process in breast cancer is related to the expression of the epithelial-to-
mesenchymal transition transcription factors (EMT-TFs) SNAIL, SLUG, SIP1 and TWIST1 …

Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives

F Seker-Polat, N Pinarbasi Degirmenci, I Solaroglu… - Cancers, 2022 - mdpi.com
Simple Summary The estimated survival time for glioblastoma patients is extremely low; only
about 5% of patients survive five years post diagnosis. The standard of care for glioblastoma …

The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment

D Laha, R Grant, P Mishra, N Nilubol - Frontiers in immunology, 2021 - frontiersin.org
The tumor microenvironment (TME) is an intricate system within solid neoplasms. In this
review, we aim to provide an updated insight into the TME with a focus on the effects of …

Tumor necrosis factor α blockade: an opportunity to tackle breast cancer

MF Mercogliano, S Bruni, PV Elizalde… - Frontiers in …, 2020 - frontiersin.org
Breast cancer is the most frequently diagnosed cancer and the principal cause of mortality
by malignancy in women and represents a main problem for public health worldwide. Tumor …

Cancer cell plasticity: Impact on tumor progression and therapy response

V da Silva-Diz, L Lorenzo-Sanz… - Seminars in cancer …, 2018 - Elsevier
Most tumors exhibit intra-tumor heterogeneity, which is associated with disease progression
and an impaired response to therapy. Cancer cell plasticity has been proposed as being an …